Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3990 |  ICCC ImmuCell Corporation - Common Stock | 10.00 USD | -0.60% | +0.60% | -9.91% | +64.47% | 90.82 M USD | ||
| 3997 |  RLYB Rallybio Corporation - Common Stock | 16.54 USD | -2.42% | -3.84% | +0.43% | +2567.74% | 87.84 M USD | ||
| 4010 |  GANX Gain Therapeutics, Inc. - Common Stock | 1.95 USD | -2.99% | -6.70% | +8.94% | -1.52% | 85.11 M USD | ||
| 4019 |  ACET Adicet Bio, Inc. - Common Stock | 8.85 USD | -3.70% | +2.08% | +12.17% | +1112.33% | 82.85 M USD | ||
| 4024 |  ELOX Eloxx Pharmaceuticals, Inc. | 19.78 USD | -5.67% | +7.68% | +67.77% | +97.80% | 79.84 M USD | ||
| 4027 |  MAIA MAIA Biotechnology, Inc. Common Stock | 1.34 USD | -3.60% | -1.47% | +3.88% | -35.58% | 81.51 M USD | ||
| 4040 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 4.76 USD | -1.24% | -4.99% | -6.30% | -20.93% | 81.77 M USD | ||
| 4049 |  OKYO OKYO Pharma Limited - American Depositary Shares | 1.54 USD | 0.00% | +1.32% | -0.65% | -40.77% | 80.82 M USD | ||
| 4052 |  CING Cingulate Inc. - Common Stock | 5.46 USD | -1.62% | +4.60% | +16.17% | -11.36% | 79.40 M USD | ||
| 4063 |  ELTX Elicio Therapeutics, Inc. - Common Stock | 2.99 USD | -1.64% | -2.92% | -2.92% | -70.10% | 78.58 M USD | ||
| 4075 |  TELO Telomir Pharmaceuticals, Inc. - Common Stock | 1.16 USD | +2.65% | +8.41% | 0.00% | -20.00% | 79.78 M USD | ||
| 4077 |  ANVS Annovis Bio, Inc. Common Stock | 1.77 USD | -2.75% | -2.21% | +5.99% | -25.94% | 75.41 M USD | ||
| 4079 |  NRXS Neuraxis, Inc. Common Stock | 6.02 USD | -2.11% | -6.81% | -10.28% | +10.87% | 75.60 M USD | ||
| 4108 |  GOSS Gossamer Bio, Inc. - Common Stock | 0.15 USD | 0.00% | 0.00% | -11.76% | -93.59% | 73.33 M USD | ||
| 4110 |  SER Serina Therapeutics, Inc. Common Stock | 2.82 USD | -1.74% | +1.44% | +41.00% | +68.86% | 71.63 M USD | ||
| 4113 |  LONA LeonaBio, Inc. - Common Stock | 7.60 USD | -1.04% | -4.04% | +2.70% | +12.76% | 71.60 M USD | ||
| 4118 |  PLRX Pliant Therapeutics, Inc. - Common Stock | 1.13 USD | -2.59% | +2.73% | +4.63% | -22.07% | 69.97 M USD | ||
| 4127 |  PMVP PMV Pharmaceuticals, Inc. - Common Stock | 1.32 USD | -0.75% | +4.76% | +6.45% | -11.41% | 70.56 M USD | ||
| 4128 |  SPRO Spero Therapeutics, Inc. - Common Stock | 1.21 USD | -0.82% | -0.82% | -0.82% | -35.98% | 70.46 M USD | ||
| 4129 |  IBIO iBio, Inc. - Common Stock | 1.39 USD | -2.80% | -5.44% | -3.47% | -39.57% | 69.05 M USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |